Page 88 - Demo

40. Xu XL, Zhang W, Rao GW. Clinical Applicationand Synthesis Methods of Deuterated Drugs.Curr Med Chem. 2023; 30(36): 4096-4129.doi:10.2174/092986733066622112212320141. P%u00e9rez G%u00f3mez MV, S%u00e1nchez Ni%u00f1o MD, Sanz AB,Zheng B, Mart%u00edn Cleary C, Ruiz Ortega M, etal. Targeting inflammation in diabetic kidneydisease: early clinical trials. Expert OpinInvestig Drugs. 2016 Sep; 25(9): 1045-58.doi:10.1080/13543784.2016.119618442. Goto S, Kamiyoshi T, Iwasaki R. Predictivefactors associated with short-term mortalityin cats with feline infectious peritonitistreated with remdesivir or GS-441524 orboth. J Vet Intern Med. 2025 Jan-Feb; 39(1):e17249. doi:10.1111/jvim.1724943. Zhang X, Gaetani M, Chernobrovkin A, ZubarevRA. Anticancer Effect of Deuterium DepletedWater - Redox Disbalance Leads to OxidativeStress*. Molecular & Cellular Proteomics.2019; 18(12): 2373-2387.https://doi.org/10.1074/mcp.RA119.00145 32. Cu%u00e9llar Rodr%u00edguez S. Novel drugs recentlyauthorized by EMA and FDA (Q4, 2024).ANALES RANF [Internet]. Real AcademiaNacional de Farmacia; An. Real Acad. Farm.%u00b7 A%u00f1o 2024 %u00b7 volumen 90 %u00b7 n%u00famero 04 [inpress]33. Cu%u00e9llar Rodr%u00edguez S. F%u00e1rmacos novedososautorizados recientemente%u00a0 por EMA y FDA(1%u00ba trimestre de 2023). ANALES RANF[Internet]. Real Academia Nacional deFarmacia; An Real Acad Farm A%u00f1o 2023.Volumen 89 N%u00famero 1 pp. 127-134.DOI:%u00a0https://doi.org/10.53519/analesranf.2023.89.01.07 34. Cu%u00e9llar Rodr%u00edguez S. F%u00e1rmacos novedososautorizados recientemente por EMA y FDA (3%u00batrimestre de 2022). ANALES RANF [Internet].Real Academia Nacional de Farmacia; AnReal Acad Farm A%u00f1o 2022. Volumen 88N%u00famero 3. pp. 323-335.DOI:%u00a0https://doi.org/10.53519/analesranf.2022.88.03.06 35. National Cancer Institute. deuteratedenzalutamide.https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deutenzalutamide(consultado el 6 de enero de 2025)36. Cao Y, Yu F, Lyu Y, Lu X. Promising candidatesfrom drug clinical trials: Implications forclinical treatment of Alzheimer%u2019s disease inChina. Front Neurol. 2022 Nov 15; 13:1034243. doi:10.3389/fneur.2022.103424337. Palfreyman M, Krakowsky J, Morgan M, CanalC, Pathare P, Avery K, et al. . %u201cACNP 61stAnnual Meeting: Poster Abstracts P271-P540:P361. In Vitro and In Vivo Profile of CYB003:A Novel, Deuterated Psilocybin Analog forthe Potential Treatment of Major DepressiveDisorder%u201d (PDF). Neuropsychopharmacology.2022; 47 (Suppl 1): 220%u2013370 (271).doi:10.1038/s41386-022-01485-038. Wo JM, McCallum RW, Gonzalez Z . %u201cAntiemetictherapy for gastroparesis%u201d. In McCallum RW,Parkman HP (eds.). Gastroparesis. Elsevier.(2021) pp. 341%u2013359. doi:10.1016/B978-0-12-818586-5.00025-9 39. Harrison SA, Thang C, Bolze S, Dewitt S, HallakouBozec S, Dubourg J, et al. Evaluation of PXL065 -deuterium-stabilized (R)-pioglitazone in patientswith NASH: A phase II randomized placebocontrolled trial (DESTINY-1). J Hepatol. 2023 May;78(5): 914-925. doi:10.1016/j.jhep.2023.02.004 470ANALESRANFwww.analesranf.comDeuterium in PharmacologySantiago Cu%u00e9llar Rodr%u00edguezAn. R. Acad. Farm.Vol. 90. n%u00ba4 (2024) %u00b7 pp. 449-470Si desea citar nuestro art%u00edculo:Deuterio en Farmacolog%u00edaSantiago Cu%u00e9llar Rodr%u00edguezAn Real Acad Farm (Internet).An. Real Acad. Farm.Vol. 90. n%u00ba 4 (2024) %u00b7 pp. 449-470DOI:http://dx.doi.org/10.53519/analesranf.2024.90.04.03